What Makes Insmed Incorporated (INSM) a Prospective Investment?
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Insmed Inc (INSM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Neo Ivy Capital Renee Yao | 18,436 | $1,235 | 0.24% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.29 | 10,000 | Director | 10,000 | 2023-05-15 | Filing | |
| $19.29 | 10,000 | Director | 298,615 | 2023-05-15 | Filing | |
| $17.70 | 10,000 | Director | 15,900 | 2022-11-01 | Filing | |
| $17.53 | 20,000 | Director | 281,021 | 2022-10-31 | Filing | |
| $17.69 | 45,000 | Director | 98,265 | 2022-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $60.00 | 21,195 | Officer | 106,134 | 2024-06-10 | Filing | |
| $55.33 | 55,000 | Officer | 108,760 | 2024-06-03 | Filing | |
| $50.00 | 6,250 | Officer | 121,657 | 2024-05-28 | Filing | |
| $48.95 | 1,602 | Officer | 121,657 | 2024-05-28 | Filing | |
| $49.53 | 44,722 | Officer | 88,828 | 2024-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,125,521 | $437,749,895 | 0% | |
| 2. | 11,492,282 | $356,145,819 | 0% | |
| 3. | 5,929,933 | $183,768,624 | 0% | |
| 4. | 5,091,614 | $157,789,126 | 0.01% | |
| 5. | 4,651,492 | $144,150,000 | 0.16% |
News See All
7 Best Mid-Cap Healthcare Stocks To Buy Now
The healthcare industry is considered to be a fairly defensive sector due to its need.
Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript
Insmed Incorporated beats earnings expectations. Reported EPS is $-1.05817, expectations were $-1.21.
What Makes Insmed (INSM) a Lucrative Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript
Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.28 EPS, expectations were $-1.13.
5 Best Strong Buy Stocks To Invest In
In this piece, we will take a look at the five best strong buy stocks to invest in.
12 Most Promising Stocks to Buy According to Hedge Funds
In this article, we will take a look at the 12 most promising stocks to buy according to hedge funds.
Insmed Incorporated (NASDAQ:INSM) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Caleb Baker and I will be your conference operator today.
Insmed Incorporated (NASDAQ:INSM) Q2 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Enrique, and I'll be your conference operator today.
Insmed Incorporated (NASDAQ:INSM) Q1 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Insmed First Quarter 2023 Financial Results. My name is Nandaja, and I will be your operator today.
Billionaire Hedge Funds
